Another consequence of the basal activation of platelets from patients with SLE is the enhancement of their interaction with leukocytes (present results and other authors [26,27]) through the binding of P-selectin with the PSGL-1 present on the leukocytes’ surface. The gene discussed is SELPLG; the disease is systemic lupus erythematosus.